UBS Group’s Aspira Women's Health Inc. Common Stock AWH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-34,196
| Closed | -$3.21K | – | 11225 |
|
|
2025
Q1 | $3.21K | Buy |
34,196
+32,151
| +1,572% | +$10.1K | ﹤0.01% | 9239 |
|
|
2024
Q4 | $1.44K | Buy |
2,045
+200
| +11% | +$163 | ﹤0.01% | 9233 |
|
|
2024
Q3 | $1.49K | Buy |
1,845
+796
| +76% | +$884 | ﹤0.01% | 8623 |
|
|
2024
Q2 | $1.56K | Hold |
1,049
| – | – | ﹤0.01% | 8549 |
|
|
2024
Q1 | $3.25K | Buy |
1,049
+668
| +175% | +$2.89K | ﹤0.01% | 7757 |
|
|
2023
Q4 | $1.55K | Hold |
381
| – | – | ﹤0.01% | 8276 |
|
|
2023
Q3 | $2.04K | Hold |
381
| – | – | ﹤0.01% | 7780 |
|
|
2023
Q2 | $1.26K | Hold |
381
| – | – | ﹤0.01% | 7966 |
|
|
2023
Q1 | $2.09K | Hold |
381
| – | – | ﹤0.01% | 8583 |
|
|
2022
Q4 | $1.89K | Buy |
+381
| New | +$2.08K | ﹤0.01% | 9774 |
|
|
2022
Q2 | – | Sell |
-234
| Closed | -$4K | – | 11209 |
|
|
2022
Q1 | $4K | Sell |
234
-1,642
| -88% | -$28.5K | ﹤0.01% | 9349 |
|
|
2021
Q4 | $50K | Buy |
+1,876
| New | +$71.2K | ﹤0.01% | 6899 |
|
|
2021
Q3 | – | Sell |
-13
| Closed | -$1K | – | 10268 |
|
|
2021
Q2 | $1K | Sell |
13
-1,455
| -99% | -$125K | ﹤0.01% | 9218 |
|
|
2021
Q1 | $149K | Buy |
1,468
+391
| +36% | +$43K | ﹤0.01% | 5666 |
|
|
2020
Q4 | $108K | Buy |
1,077
+1,009
| +1,484% | +$67.4K | ﹤0.01% | 5640 |
|
|
2020
Q3 | $3K | Sell |
68
-248
| -78% | -$12.7K | ﹤0.01% | 7580 |
|
|
2020
Q2 | $18K | Buy |
+316
| New | +$21.1K | ﹤0.01% | 6632 |
|
Other funds holding AWH
UBS Group's AWH Position: Q2 2025 in Review
UBS Group sold out of Aspira Women's Health Inc. Common Stock (AWH) in Q2 2025, closing a stake of 34,196 shares — an estimated $3.21K sold.
UBS Group first reported a position in AWH in Q2 2020 and held it in 17 quarters. The position peaked at $149K in Q1 2021. 2 funds tracked by Wall St. Rank hold AWH as of Q2 2025.
- UBS Group reported no remaining Aspira Women's Health Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
- UBS Group sold 34,196 Aspira Women's Health Inc. Common Stock shares in Q2 2025, an estimated $3.21K.
- UBS Group first reported a position in Aspira Women's Health Inc. Common Stock in Q2 2020 and held it in 17 quarters.
- UBS Group's Aspira Women's Health Inc. Common Stock position peaked at $149K in Q1 2021.
- 2 funds tracked by Wall St. Rank held Aspira Women's Health Inc. Common Stock as of Q2 2025.
Based on UBS Group's 13F filing for Q2 2025, filed 14 Aug 2025.